John E. Sagartz, Director, 10% Owner at BIOANALYTICAL SYSTEMS INC (BASI), bought 1,400 shares at $1.94 ($3K) on 2019-03-14, disclosed to the SEC on 2019-03-14.
Open-market purchase of $3k BASI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NOTV | SELL | 2025-02-04 | $9K | — | Filing → |
| NOTV | BUY | 2023-03-16 | $25K | — | Filing → |
| NOTV | BUY | 2022-02-17 | $50K | — | Filing → |